Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction.

Mattia Galli,Stefano Migliaro,Daniele Rodolico, Gaetano DI Stefano,Carlo Piccinni,Attilio Restivo,Felicita Andreotti,Rocco Vergallo,Rocco A Montone,George Besis,Antonino Buffon,Enrico Romagnoli,Cristina Aurigemma,Antonio M Leone,Francesco Burzotta,Giampaolo Niccoli,Carlo Trani,Filippo Crea,Domenico D'Amario

Minerva cardiology and angiology（2022）

引用 4|浏览0

暂无评分

摘要

In a contemporary real-world population of STEMI patients undergoing PPCI, the use of intracoronary GPIs bolus-only in selected patients at high ischemic risk is safe and could represent a useful antithrombotic strategy both in those pretreated and in those naïve to P2Y12 inhibitors.

查看译文

关键词

ST elevation myocardial infarction, Platelet aggregation inhibitors, Myocardial bridging

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要